Coherus BioSciences Lands $85,050,000 New Financing

  • Feed Type
  • Date
    11/7/2014
  • Company Name
    Coherus BioSciences
  • Mailing Address
    201 Redwood Shores Parkway Redwood City, CA 94065 USA
  • Company Description
    Coherus BioSciences, Inc. (NASDAQ: CHRS) is focused on delivering high quality biosimilar therapeutics that will expand the access of important medicines to patients worldwide.
  • Website
    http://www.coherus.com
  • Transaction Type
    IPO
  • Transaction Amount
    $85,050,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes are on file with company statements at the SEC.
  • M&A Terms

Trending on Xconomy